2010
DOI: 10.1074/jbc.m110.117465
|View full text |Cite
|
Sign up to set email alerts
|

Two Modes of β-Receptor Recognition Are Mediated by Distinct Epitopes on Mouse and Human Interleukin-3

Abstract: The cytokine interleukin-3 (IL-3) is a critical regulator of inflammation and immune responses in mammals. IL-3 exerts its effects on target cells via receptors comprising an IL-3-specific ␣-subunit and common ␤-subunit (␤c; shared with IL-5 and granulocyte-macrophage colony-stimulating factor) or a ␤-subunit that specifically binds IL-3 (␤ IL-3 ; present in mice but not humans). We recently identified two splice variants of the ␣-subunit of the IL-3 receptor (IL-3R␣) that are relevant to hematopoietic progeni… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
11
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(12 citation statements)
references
References 43 publications
1
11
0
Order By: Relevance
“…The differential effects observed for ligand binding by h␤c and ␤ IL-3 when co-expressed with the full-length IL-3␣ (SP1) or the splice variant lacking the N-terminal Ig-like domain (SP2) are consistent with our prior work suggesting that the two IL-3␣ isoforms dictate which of two distinct IL-3 binding interfaces on the ␤ receptors are used (25,31,47). It is clear that the ligand-binding epitopes on h␤c and ␤ IL-3 utilized by the IL-3⅐IL-3R␣ SP2 complex are the most affected by disruption of the domain 1 D-E loop disulfide.…”
Section: Discussionsupporting
confidence: 71%
“…The differential effects observed for ligand binding by h␤c and ␤ IL-3 when co-expressed with the full-length IL-3␣ (SP1) or the splice variant lacking the N-terminal Ig-like domain (SP2) are consistent with our prior work suggesting that the two IL-3␣ isoforms dictate which of two distinct IL-3 binding interfaces on the ␤ receptors are used (25,31,47). It is clear that the ligand-binding epitopes on h␤c and ␤ IL-3 utilized by the IL-3⅐IL-3R␣ SP2 complex are the most affected by disruption of the domain 1 D-E loop disulfide.…”
Section: Discussionsupporting
confidence: 71%
“…Although the location of these additional βc‐contact residues in human IL‐3 remains unknown, extensive mutagenesis studies of residues in helix C indicate that this region is not essential for IL‐3 function. The discovery of splice isoforms of the human and murine IL3Rα subunits lacking the NTD has revealed an interesting variation in IL‐3 interaction with the β‐subunit provided by the two isoforms . Thus, hIL‐3 E22A is a weak agonist through the full‐length IL3Rα isoform (SP1), but is completely devoid of agonist activity in the context of the IL3Rα isoform (SP2) lacking the NTD.…”
Section: Il‐3 and Its Receptormentioning
confidence: 99%
“…Thus, hIL‐3 E22A is a weak agonist through the full‐length IL3Rα isoform (SP1), but is completely devoid of agonist activity in the context of the IL3Rα isoform (SP2) lacking the NTD. Murine IL‐3 mutated at the critical conserved glutamate, E23A, is a full agonist on cells expressing murine IL3Rα SP1 and βIL‐3, but is completely devoid of agonist activity on cells expressing murine IL3Rα SP2 and βIL‐3 as well as being unable to directly bind βIL‐3 . Additional residues in mIL‐3 have also been identified as functionally important βIL‐3 contact residues including K27 in helix A and E65, V69, and N73 in helix C although, apart from E65, the importance of these additional contacts is largely revealed only in the presence of IL3Rα SP2 .…”
Section: Il‐3 and Its Receptormentioning
confidence: 99%
See 1 more Smart Citation
“…The X-ray structure of the hβc is an intertwined homodimer in which each chain contains four domains with approximate fibronectin type-III topology. 80 ) By fluorescence resonance energy transfer imaging, βc subunit is demonstrated to exist as preformed homo-oligomers and the IL-5 stimulation induces βc assembly in the presence of IL-5Rα. 81 )…”
Section: Il-5 Receptormentioning
confidence: 99%